Formulations of phospholipase enzyme inhibitors
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- WYETH LLC
- Publication Date
- 2009-11-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] Cross References to Related Applications
[0002] This application claims the benefit of US Provisional Patent Application No. 60 / 855,569, filed October 31, 2006, which is incorporated herein by reference in its entirety. field of invention
[0003] The present invention relates to phospholipases (e.g. cytosolic PLA 2 ) inhibitor formulations, compositions containing the same and methods for their preparation. Background of the invention
[0004] Leukotrienes and prostaglandins are important mediators of inflammation, and they participate in the establishment of inflammatory responses in different ways. Leukotrienes recruit inflammatory cells such as neutrophils to sites of inflammation, facilitate extravasation of these cells and stimulate the release of tissue-damaging superoxide and proteases. Leukotrienes also play a pathophysiological role in asthma-induced hypersensitivity [see, eg, B. Samuelson et al., Science, 237:1171-76 (1987)]. Prostaglandins enhance th...